Marinus Pharmaceuticals Trading News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marinus pharmaceuticals trading. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marinus Pharmaceuticals Trading Today - Breaking & Trending Today

Marinus Pharmaceuticals (MRNS) Set to Announce Earnings on Wednesday

Marinus Pharmaceuticals (MRNS) Set to Announce Earnings on Wednesday
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , Marinus Pharmaceuticals Inc , Cantor Fitzgerald , News Ratings For Marinus Pharmaceuticals Daily , Marinus Pharmaceuticals Trading , Marinus Pharmaceuticals , Earnings History For Marinus Pharmaceuticals , Royal Bank , Get Free Report , Marinus Pharmaceuticals Daily ,

Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target Lowered to $11.00 at HC Wainwright

Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target Lowered to $11.00 at HC Wainwright
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , Cantor Fitzgerald , Marinus Pharmaceuticals , Marinus Pharmaceuticals Company Profile , Royal Bank , Sg Americas Securities , Institutional Trading Of Marinus Pharmaceuticals , Analyst Recommendations For Marinus Pharmaceuticals , News Ratings For Marinus Pharmaceuticals Daily , China Universal Asset Management Co , Sherbrooke Park Advisers , Marinus Pharmaceuticals Trading , Marinus Pharmaceuticals Inc , Acuta Capital Partners , Get Free Report , Universal Asset Management , Park Advisers , Capital Partners , Trexquant Investment , Marinus Pharmaceuticals Daily ,

HC Wainwright Reiterates "Buy" Rating for Marinus Pharmaceuticals (NASDAQ:MRNS)

HC Wainwright Reiterates "Buy" Rating for Marinus Pharmaceuticals (NASDAQ:MRNS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hedge Funds Weigh In On Marinus Pharmaceuticals , Charles Schwab Investment Management Inc , Goldman Sachs Group Inc , Marinus Pharmaceuticals Trading , Analyst Recommendations For Marinus Pharmaceuticals , Royal Bank , Renaissance Technologies , Marinus Pharmaceuticals Inc , News Ratings For Marinus Pharmaceuticals Daily , Metlife Investment Management , Marinus Pharmaceuticals , Get Free Report , Life Investment Management , Schwab Investment Management , Sachs Group , Quantbot Technologies , Marinus Pharmaceuticals Daily ,

Marinus Pharmaceuticals' (MRNS) Outperform Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a research note released on Wednesday morning, Benzinga reports. They currently have a $24.00 target price on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on the stock. Truist Financial cut […] ....

Institutional Trading Of Marinus Pharmaceuticals , Marinus Pharmaceuticals Inc , Ameritas Investment Partners Inc , Marinus Pharmaceuticals Trading , Marinus Pharmaceuticals , Royal Bank , Analyst Recommendations For Marinus Pharmaceuticals , News Ratings For Marinus Pharmaceuticals Daily , Bluepath Capital Management , Life Insurance Co , Marinus Pharmaceuticals Company Profile , Free Report , Moderate Buy , Get Free Report , Path Capital Management , Ameritas Investment Partners , Marinus Pharmaceuticals Daily ,

228,714 Shares in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Acquired by Altium Capital Management LP

Altium Capital Management LP acquired a new stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 228,714 shares of the biopharmaceutical company’s stock, valued at approximately $1,578,000. Altium Capital Management LP owned about 0.45% of Marinus […] ....

Scott Braunstein , Steven Pfanstiel , Marinus Pharmaceuticals , Denali Advisors , News Ratings For Marinus Pharmaceuticals Daily , Quarter For Marinus Pharmaceuticals , Marinus Pharmaceuticals Trading , Marinus Pharmaceuticals Inc , Securities Exchange Commission , Marinus Pharmaceuticals Company Profile , Altium Capital Management , Free Report , Capital Management , Street Group , Get Free Report , Exchange Commission , Marinus Pharmaceuticals Daily , Nasdaq Mrns , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,